We are pleased to announce that OPS has been appointed as one of the select distributors of the newly licensed Epistatus (Midazolam) Oromucosal Solutions, from Veriton Pharma Ltd.
Epistatus is indicated for the treatment of prolonged and acute convulsive seizures in infants, toddlers and children aged from 3 months to 18 years.
Please click the below links for further product information.
These are all in stock and available as required.
You must be logged in to view this page.